// App-Quantinova.ai

529 : Soluble CD40 Ligand Stimulates the Pro-angiogenic Function of Early Endothelial Progenitor Cells by Increasing Matrix Metalloproteinase 9 Release via the p38 Mitogen-Activated Protein Kinase Pathway

Researchers

Presenter

  • Ahmed Hachem

Principal Investigators

  • Younes Zaid

  • Walid Mourad

  • Yahye Merhi

Medical Centers

  • University of Montreal, Montreal, QC, Canada

  • Montreal, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Nucleoside diphosphate kinase A

  • Cluster of Differentiation 40

  • Endothelial cell nitric oxide synthase

  • Soluble CD40

Drug/Treatment

  • Sapropterin

  • Angiotensin II

  • Nitric oxide

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved